Tag: biopharma,

Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio…

GlobeNews Wire GlobeNews Wire

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

February 07, 2025 16:05 ET  | Source: AEON Biopharma IRVINE, Calif., Feb.…

GlobeNews Wire GlobeNews Wire

Matinas BioPharma Receives NYSE Noncompliance Notice

January 10, 2025 17:15 ET  | Source: Matinas BioPharma Holdings, Inc. BEDMINSTER,…

GlobeNews Wire GlobeNews Wire

Matinas BioPharma Receives NYSE Noncompliance Notice

January 10, 2025 17:15 ET  | Source: Matinas BioPharma Holdings, Inc. BEDMINSTER,…

GlobeNews Wire GlobeNews Wire

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan.…

GlobeNews Wire GlobeNews Wire

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan.…

GlobeNews Wire GlobeNews Wire

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

January 03, 2025 20:02 ET  | Source: AEON Biopharma IRVINE, Calif., Jan.…

GlobeNews Wire GlobeNews Wire

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

January 03, 2025 20:02 ET  | Source: AEON Biopharma IRVINE, Calif., Jan.…

GlobeNews Wire GlobeNews Wire